Evidence map›Paper›PMID 35138610›Full record

ArticleAdvances in experimental medicine and biology2021

The Polysite Pharmacology of TREK K

Lianne Pope, Daniel L Minor

Abstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Mechanosensitive receptors in migraine: a systematic review.The journal of headache and pain · 2024
    Pooled it
  2. Cryo-EM structure of the human THIK-1 K2P KNature structural & molecular biology · 2025
    Article
  3. Structure of the human TWIK-2 potassium channel and its inhibition by pimozide.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Development of covalent chemogenetic KCell chemical biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Development of covalent chemogenetic KbioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lianne PopeCardiovascular Research Institute, University of California San Francisco, San Francisco, CA, US.
Daniel L MinorCardiovascular Research Institute, University of California San Francisco, San Francisco, CA, US. daniel.minor@ucsf.edu.

Funding

Genetic and chemical biological studies of K2P structure, function, andmodulationR01MH093603 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL L MINOR · 2011 to 2026
$8.5M
NIMH NIH HHS R01 MH093603
6 · The paper itself

Abstract

K

Indexed as

NeuronsBinding SitesHumansFluoxetineK2P channelML335/ML402PIP2Ruthenium redTREK subfamily

Identifiers

PMID35138610
PMCPMC8887811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.